CV Sciences, Inc.
CVSI · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $4 | $4 | $4 |
| % Growth | -100% | 0.4% | -7.2% | – |
| Cost of Goods Sold | $0 | $2 | $2 | $2 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | – | 50.9% | 46% | 43.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $2 | $1 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | -$1 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$0 | -$0 | $0 | -$1 |
| % Margin | – | -3.6% | 0.3% | -16.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | -7.2% | -3% | -18.7% |
| EPS | -0.002 | -0.001 | -0.001 | -0.004 |
| % Growth | -50% | -133.3% | 84.6% | – |
| EPS Diluted | -0.002 | -0.001 | -0.001 | -0.004 |
| Weighted Avg Shares Out | 184 | 184 | 184 | 184 |
| Weighted Avg Shares Out Dil | 184 | 184 | 184 | 184 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | $0 | -$1 |
| % Margin | – | -2% | 2.6% | -15.9% |